Rosacea and the cardiovascular system.
flushing
hypertension
metabolic syndrome
obesity
rosacea
smoking
Journal
Journal of cosmetic dermatology
ISSN: 1473-2165
Titre abrégé: J Cosmet Dermatol
Pays: England
ID NLM: 101130964
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
18
06
2020
revised:
24
06
2020
accepted:
26
06
2020
pubmed:
6
7
2020
medline:
15
5
2021
entrez:
5
7
2020
Statut:
ppublish
Résumé
Rosacea and the cardiometabolic syndrome are both associated with chronic inflammation and a pro-inflammatory phenotype. Emerging clinical evidence supports the relationship between rosacea and cardiometabolic syndrome hypertension and obesity. This article reviews our current findings and understanding in the skin and cardiovascular relationship in rosacea. Rosacea appears to be associated with hypertension, dyslipidemia, and obesity. The role of smoking in rosacea is currently less clear. It remains uncertain whether treatment of these risk factors will aid improvement of rosacea. Greater understanding of rosacea and its association with the cardiovascular system and underlying risk factors could allow for a greater understanding of the body's inflammatory response as well as the formulation of new guidelines for attending clinicians. Dermatologists treating rosacea patients might need to consider enquiring and evaluate their patients' underlying cardiovascular risk factors.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2182-2187Informations de copyright
© 2020 Wiley Periodicals, LLC.
Références
Tan J, Almeida LM, Bewley A, et al. Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROSacea COnsensus (ROSCO) panel. Br J Dermatol. 2017;176(2):431-438.
Sinikumpu S, Jokelainen J, Auvinen J, et al. Increased risk of cardiovascular diseases in female rosacea patients: a nested case-control study. Acta dermatol. 2019;99(7-8):705-706.
Sharma P. Inflammation and the metabolic syndrome. Indian J Clin Biochem. 2011;26(4):317-318.
Esposito K, Giugliano D. The metabolic syndrome and inflammation: association or causation? Nutr Metab Cardiovasc Dis. 2004;14:228-232.
Pro-Inflammatory SG, Factors P, Syndrome M. EJIFCC. 2007;18(1):39-46.
Dosal J, Keri J. Rosacea and cardiovascular disease: Is there an association? J Am Acad Dermatol. 2015;73(2):308-309.
Haber R, El Gemayel M. Comorbidities in rosacea: a systematic review and update. ? J Am Acad Dermatol. 2018;78(4):786-792.
Duman N, Ersoy Evans S, Atakan N. Rosacea and cardiovascular risk factors: a case control study. J Eur Acad Dermatol Venereol. 2014;28(9):1165-1169.
Vera N, Patel NU, Seminario-Vidal L. Rosacea comorbidities. Dermatol Clin. 2018;36(2):115-122.
van Zuuren EJ. Rosacea. N Engl J Med. 2017;377:1754-1764.
Gerber PA, Buhren BA, Steinhoff M, Homey B. Rosacea: the cytokine and chemokine network. J Investig Dermatol Symp Proc. 2011;15(1):40-47.
Yamasaki K, Gallo RL. Rosacea as a disease of cathelicidins and skin innate immunity. J Investig Dermatol Symp Proc. 2011;15:12-15.
Yamasaki K, Di Nardo A, Bardan A, et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med. 2007;13:975-980.
Rainer BM, Kang S, Chien AL. Rosacea: Epidemiology, pathogenesis, and treatment. Dermatoendocrinol. 2017;9(1):e1361574.
Chen QI, Shi X, Tang Y, et al. Association between rosacea and cardiometabolic disease: a systematic review and meta-analysis. J Am Acad Dermatol. 2020. https://doi.org/10.1016/j.jaad.2020.04.113
Hua T-C, Chung P-I, Chen Y-J, et al. Cardiovascular comorbidities in patients with rosacea: a nationwide case-control study from Taiwan. J Am Acad Dermatol. 2015;73(2):249-254.
Belli AA, Altun I, Altun I. Thickness of carotid intima and epicardial fat in rosacea: a cross-sectional study. An Bras Dermatol. 2017;92(6):820-825.
Egeberg A, Fowler JF, Gislason GH, Thyssen JP. Nationwide assessment of cause-specific mortality in patients with rosacea: A cohort study in Denmark. Am J Clin Dermatol. 2016;17(6):673-679.
Stefanadi EC, Dimitrakakis G, Antoniou C-K, et al. Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients. Diabetol Metab Syndr. 2018;10(1):9.
Guida S, Galimberti MG, Bencini M, Pellacani G, Bencini PL. Telangiectasia of the face: risk factors for reappearance in patients treated with dye laser. J Eur Acad Dermatol Venereol. 2017;31(8):1355-1359.
Darabian S, Hormuz M, Latif MA, Pahlevan S, Budoff MJ. The role of carotid intimal thickness testing and risk prediction in the development of coronary atherosclerosis. Curr Atheroscler Rep. 2013;15(3):306.
Casas C, Paul C, Lahfa M, et al. Quantification of Demodex folliculorum by PCR in rosacea and its relationship to skin innate immune activation. Exp Dermatol. 2012;21:906-910.
Melnik BC. Endoplasmic reticulum stress: key promoter of rosacea pathogenesis. Exp Dermatol. 2014;23:868-873.
Meier CR, Derby LE, Jick SS, Vasilakis C, Jick H. Antibiotics and risk of subsequent first-time acute myocardial infarction. JAMA. 1999;281(5):427-431.
Belli AA, Gok SO, Akbaba G, Etgu F, Dogan G. The relationship between rosacea and insulin resistance and metabolic syndrome. Eur J Dermatol. 2016;26(3):260-264.
Li S, Cho E, Drucker AM, Qureshi AA, Li WQ. Obesity and risk for incident rosacea in US women. J Am Acad Dermatol. 2017;77(6):1083-1087.
Aksoy B, Ekiz Ö, Unal E, et al. Systemic comorbidities associated with rosacea: a multicentric retrospective observational study. Int J Dermatol. 2019;58(6):722-728.
Rainer BM, Fischer AH, Da Silva DL, Kang S, Chien AL. Rosacea is associated with chronic systemic diseases in a skin severity-dependent manner: results of a case-control study. J Am Acad Dermatol. 2015;73(4):604-608.
Natale F, Cirillo C, Granato C, et al. Worsening of rosacea in patients treated with dihydropyridine calcium channel blockers: a clinical observation. Hypertens Res. 2011;34(6):790-791.
Spoendlin J, Voegel JJ, Jick SS, Meier CR. Antihypertensive drugs and the risk of incident rosacea. Br J Dermatol. 2014;171(1):130-136.
Powell FC. What's going on in rosacea? J Eur Acad Dermatol Venereol. 2000;14:351-352.
Son JH, Chung BY, Jung MJ, Choi YW, Kim HO, Park CW. The risk of rosacea according to chronic diseases and medications: a 5-year retrospective. Multi-institutional case-control study. Ann Dermatol. 2018;30(6):676-687.
Diamantis E, Kyriakos G, Quiles-Sanchez LV, Farmaki P, Troupis T. The anti-inflammatory effects of statins on coronary artery disease: an updated review of the literature. Curr Cardiol Rev. 2017;13(3):209-216.
Jowkar F, Namazi MR. Statins in dermatology. Int J Dermatol. 2010;49:1235-1243.
Katsumoto M, Shingu T, Kuwashima R, Nakata A, Nomura S, Chayama K. Biphasic effect of HMG-CoA reductase inhibitor, pitavastatin, on vascular endothelial cells and angiogenesis. Circ J. 2005;69:1547-1555.
Luan Z, Chase AJ, Newby AC. Statins inhibit secretion of metalloproteinases-1,-2,-3, and -9 from vascular smooth muscle cells and macrophages. Arterioscler Thromb Vasc Biol. 2003;23:769-775.
Spoendlin J, Voegel JJ, Jick SS, Meier CR. A study on the epidemiology of rosacea in the UK. Br J Dermatol. 2012;167(3):598-605.
Li S, Cho E, Drucker AM, Qureshi AA, Li WQ. Cigarette smoking and risk of incident rosacea in women. Am J Epidemiol. 2017;186(1):38-45.
ABRAM K, Silm H, Maaroos HI, Oona M. Risk factors associated with rosacea. J Eur Acad Dermatol Venereol. 2010;24(5):565-571. https://doi.org/10.1111/j.1468-3083.2009.03472.x
Breton AL, Truchetet F, Véran Y, et al. Prevalence analysis of smoking in rosacea. J Eur Acad Dermatol Venereol. 2011;25(9):1112-1113.
Mills CM, Marks R. Environmental factors influencing rosacea. Clin Exp Dermatol. 1996;21(2):172-173.
Edvinsson ML, Andersson SE, Xu CB, Edvinsson L. Cigarette smoking leads to reduced relaxant responses of the cutaneous microcirculation. Vasc Health Risk Manag. 2008;4(3):699-704.
Mills CM, Hill SA, Marks R. Transdermal nicotine suppresses cutaneous inflammation. Arch Dermatol. 1997;133(7):823-825.
Meirowitz N. Flushing and papules in a middle-aged woman. Obstet Gynecol. 2005;105(6):1482.
Kucukunal A, Altunay I, Arici JE, Cerman AA. Is the effect of smoking on rosacea still somewhat of a mystery. Cutan Ocul Toxicol. 2016;35(2):110-114.
Aldrich N, Gerstenblith M, Fu P, et al. Genetic vs environmental factors that correlate with rosacea: a cohort-based survey of twins. JAMA Dermatol. 2015;151(11):1213-1219.